TSCAN THERAPEUTICS, INC. (TCRX) Operating income 2020–2025
TSCAN THERAPEUTICS, INC. (TCRX) annual operating income history from SEC filings — each fiscal year as reported.
-$135.8MFY2025 · since FY2020: -$26.2M → -$135.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$135.8M | -0.7% |
| FY2024 | -$134.8M | -44.3% |
| FY2023 | -$93.5M | -40.3% |
| FY2022 | -$66.6M | -37.0% |
| FY2021 | -$48.6M | -85.4% |
| FY2020 | -$26.2M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More TCRX financial trends
TCRX RevenueTCRX Net incomeTCRX Net marginTCRX Gross profitTCRX Gross marginTCRX Operating marginTCRX Operating cash flowTCRX Free cash flowTCRX Capital expendituresTCRX Return on equityTCRX Stock buybacksTCRX Dividends paidTCRX Total assetsTCRX Total liabilitiesTCRX Shareholders’ equityTCRX overview →